Literature DB >> 23248710

Non-specific, functional, and somatoform bodily complaints.

Rainer Schaefert1, Constanze Hausteiner-Wiehle, Winfried Häuser, Joram Ronel, Markus Herrmann, Peter Henningsen.   

Abstract

BACKGROUND: 4-10% of the general population and 20% of primary care patients have what are called "non-specific, functional, and somatoform bodily complaints." These often take a chronic course, markedly impair the sufferers' quality of life, and give rise to high costs. They can be made worse by inappropriate behavior on the physician's part.
METHODS: The new S3 guideline was formulated by representatives of 29 medical and psychological specialty societies and one patient representative. They analyzed more than 4000 publications retrieved by a systematic literature search and held two online Delphi rounds and three consensus conferences.
RESULTS: Because of the breadth of the topic, the available evidence varied in quality depending on the particular subject addressed and was often only of moderate quality. A strong consensus was reached on most subjects. In the new guideline, it is recommended that physicians should establish a therapeutic alliance with the patient, adopt a symptom/coping-oriented attitude, and avoid stigmatizing comments. A biopsychosocial diagnostic evaluation, combined with sensitive discussion of signs of psychosocial stress, enables the early recognition of problems of this type, as well as of comorbid conditions, while lowering the risk of iatrogenic somatization. For mild, uncomplicated courses, the establishment of a biopsychosocial explanatory model and physical/social activation are recommended. More severe, complicated courses call for collaborative, coordinated management, including regular appointments (as opposed to ad-hoc appointments whenever the patient feels worse), graded activation, and psychotherapy; the latter may involve cognitive behavioral therapy or a psychodynamic-interpersonal or hypnotherapeutic/imaginative approach. The comprehensive treatment plan may be multimodal, potentially including body-oriented/non-verbal therapies, relaxation training, and time-limited pharmacotherapy.
CONCLUSION: A thorough, simultaneous biopsychosocial diagnostic assessment enables the early recognition of non-specific, functional, and somatoform bodily complaints. The appropriate treatment depends on the severity of the condition. Effective treatment requires the patient's active cooperation and the collaboration of all treating health professionals under the overall management of the patient's primary-care physician.

Entities:  

Mesh:

Year:  2012        PMID: 23248710      PMCID: PMC3521192          DOI: 10.3238/arztebl.2012.0803

Source DB:  PubMed          Journal:  Dtsch Arztebl Int        ISSN: 1866-0452            Impact factor:   5.594


  102 in total

Review 1.  What is the evidence for the efficacy of treatments for somatoform disorders? A critical review of previous intervention studies.

Authors:  Athula Sumathipala
Journal:  Psychosom Med       Date:  2007-12       Impact factor: 4.312

2.  The concept of prevention: a good idea gone astray?

Authors:  B Starfield; J Hyde; J Gérvas; I Heath
Journal:  J Epidemiol Community Health       Date:  2008-07       Impact factor: 3.710

3.  A shared decision-making communication training program for physicians treating fibromyalgia patients: effects of a randomized controlled trial.

Authors:  Christiane Bieber; Knut Georg Müller; Klaus Blumenstiel; Achim Hochlehnert; Stefanie Wilke; Mechthild Hartmann; Wolfgang Eich
Journal:  J Psychosom Res       Date:  2008-01       Impact factor: 3.006

4.  The diagnostic challenges presented by patients with medically unexplained symptoms in general practice.

Authors:  José M Aiarzaguena; Gonzalo Grandes; Agustín Salazar; Idoia Gaminde; Alvaro Sánchez
Journal:  Scand J Prim Health Care       Date:  2008       Impact factor: 2.581

Review 5.  Recent developments in the understanding and management of functional somatic symptoms in primary care.

Authors:  Per Fink; Marianne Rosendal
Journal:  Curr Opin Psychiatry       Date:  2008-03       Impact factor: 4.741

Review 6.  Cognitive behaviour therapy for chronic fatigue syndrome in adults.

Authors:  Jonathan R Price; Edward Mitchell; Elizabeth Tidy; Vivien Hunot
Journal:  Cochrane Database Syst Rev       Date:  2008-07-16

7.  Psychoanalytically-oriented inpatient psychotherapy of somatoform disorders.

Authors:  Manfred E Beutel; Matthias Michal; Claudia Subic-Wrana
Journal:  J Am Acad Psychoanal Dyn Psychiatry       Date:  2008

8.  Community physicians' strategies for patients with medically unexplained symptoms.

Authors:  Matt Anderson; Arthur Hartz; Terri Nordin; Marcy Rosenbaum; Russell Noyes; Paul James; John Ely; Neeraj Agarwal; Steve Anderson
Journal:  Fam Med       Date:  2008-02       Impact factor: 1.756

9.  Coordinated care in the management of patients with unexplained physical symptoms: depression is a key issue.

Authors:  Rene G Pols; Malcolm W Battersby
Journal:  Med J Aust       Date:  2008-06-16       Impact factor: 7.738

Review 10.  Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis.

Authors:  A C Ford; N J Talley; P S Schoenfeld; E M M Quigley; P Moayyedi
Journal:  Gut       Date:  2008-11-10       Impact factor: 23.059

View more
  55 in total

Review 1.  [Visceral pain].

Authors:  S Elsenbruch; W Häuser; W Jänig
Journal:  Schmerz       Date:  2015-10       Impact factor: 1.107

Review 2.  Somatoform disorders and medically unexplained symptoms in primary care.

Authors:  Heidemarie Haller; Holger Cramer; Romy Lauche; Gustav Dobos
Journal:  Dtsch Arztebl Int       Date:  2015-04-17       Impact factor: 5.594

3.  Functional Somatic Symptoms.

Authors:  Casper Roenneberg; Heribert Sattel; Rainer Schaefert; Peter Henningsen; Constanze Hausteiner-Wiehle
Journal:  Dtsch Arztebl Int       Date:  2019-08-09       Impact factor: 5.594

Review 4.  [Definition, classification, clinical diagnosis and prognosis of fibromyalgia syndrome : Updated guidelines 2017 and overview of systematic review articles].

Authors:  W Eich; K-J Bär; M Bernateck; M Burgmer; C Dexl; F Petzke; C Sommer; A Winkelmann; W Häuser
Journal:  Schmerz       Date:  2017-06       Impact factor: 1.107

Review 5.  [General treatment principles, coordination of care and patient education in fibromyalgia syndrome : Updated guidelines 2017 and overview of systematic review articles].

Authors:  F Petzke; W Brückle; U Eidmann; P Heldmann; V Köllner; T Kühn; H Kühn-Becker; M Strunk-Richter; M Schiltenwolf; M Settan; M von Wachter; M Weigl; W Häuser
Journal:  Schmerz       Date:  2017-06       Impact factor: 1.107

6.  [A weakly negative recommendation is not an absolute "no" : Comment on AWMF guideline recommendations for cannabis-based medicines in fibromyalgia syndrome].

Authors:  W Häuser; F Petzke; M Nothacker
Journal:  Schmerz       Date:  2018-10       Impact factor: 1.107

7.  In reply.

Authors:  Rainer Schaefert
Journal:  Dtsch Arztebl Int       Date:  2013-04       Impact factor: 5.594

8.  Iatrogenic chronification as a result of pseudo diagnosis.

Authors:  Rainer Hakimi
Journal:  Dtsch Arztebl Int       Date:  2013-04       Impact factor: 5.594

9.  [Neurobiology of posttraumatic and somatoform disorders in the elderly].

Authors:  M Noll-Hussong
Journal:  Z Gerontol Geriatr       Date:  2014-04       Impact factor: 1.281

10.  S3 Guideline "Management of Patients with Non-Specific, Functional and Somatoform Physical Complaints" - What is Important for Gynaecological Practice?

Authors:  F Siedentopf; C Hausteiner-Wiehle
Journal:  Geburtshilfe Frauenheilkd       Date:  2013-03       Impact factor: 2.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.